TYRA stock news · Tyra Biosciences
Get alerts for TYRA
Follow Tyra Biosciences (TYRA) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for TYRAFree on the App Store and Google Play, or on the web.
12 health care stocks are changing a lot before the market opens on Thursday.
NeutralTyra Biosciences shares rose about 21%, but the article gives no company news explaining the move. It does not change the company's outlook.
Tyra Biosciences shares dropped 21.60% on Wednesday after disappointing trial results for its drug.
NeutralTyra reported Phase 2 proof of concept and a 60 mg dose, but CR 57% missed prior expectations, leaving the clinical path intact and investor reaction mixed.